Eliem Therapeutics Inc
NASDAQ:ELYM
Eliem Therapeutics Inc
NASDAQ:ELYM
Price:
3.09
USD
-1.9%
Market Closed
Market Cap:
$207.7m
Income Statement
Earnings Waterfall
Eliem Therapeutics Inc
Eliem Therapeutics Inc
Income Statement
Eliem Therapeutics Inc
Eliem Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(21)
|
(26)
|
(33)
|
(40)
|
(36)
|
(42)
|
(47)
|
(46)
|
(45)
|
(40)
|
(32)
|
(28)
|
(21)
|
(20)
|
(70)
|
|
| Selling, General & Administrative |
(2)
|
(4)
|
(7)
|
(10)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(18)
|
(15)
|
(13)
|
(10)
|
(8)
|
(9)
|
|
| Research & Development |
(19)
|
(22)
|
(26)
|
(30)
|
(23)
|
(27)
|
(30)
|
(28)
|
(26)
|
(22)
|
(17)
|
(15)
|
(12)
|
(9)
|
(58)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(2)
|
|
| Operating Income |
(21)
N/A
|
(26)
-24%
|
(33)
-27%
|
(40)
-22%
|
(36)
+11%
|
(42)
-18%
|
(47)
-12%
|
(46)
+1%
|
(45)
+2%
|
(40)
+12%
|
(32)
+19%
|
(28)
+12%
|
(21)
+23%
|
(20)
+8%
|
(70)
-250%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
3
|
5
|
4
|
5
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(16)
|
(17)
|
(17)
|
(19)
|
0
|
0
|
|
| Total Other Income |
0
|
(12)
|
(12)
|
(12)
|
(12)
|
0
|
0
|
1
|
1
|
2
|
3
|
3
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(21)
N/A
|
(37)
-81%
|
(44)
-19%
|
(52)
-17%
|
(47)
+8%
|
(42)
+11%
|
(48)
-14%
|
(48)
0%
|
(45)
+6%
|
(54)
-20%
|
(45)
+17%
|
(39)
+13%
|
(35)
+10%
|
(15)
+59%
|
(64)
-342%
|
|
| Net Income | ||||||||||||||||
| Income from Continuing Operations |
(21)
|
(37)
|
(44)
|
(52)
|
(47)
|
(42)
|
(48)
|
(48)
|
(45)
|
(54)
|
(45)
|
(39)
|
(35)
|
(15)
|
(64)
|
|
| Net Income (Common) |
(23)
N/A
|
(40)
-76%
|
(49)
-22%
|
(57)
-17%
|
(52)
+9%
|
(46)
+12%
|
(49)
-8%
|
(48)
+3%
|
(45)
+6%
|
(54)
-20%
|
(45)
+17%
|
(39)
+13%
|
(35)
+10%
|
(15)
+59%
|
(64)
-342%
|
|
| EPS (Diluted) |
-0.91
N/A
|
-1.59
-75%
|
-1.29
+19%
|
-3.67
-184%
|
-4.24
-16%
|
-1.73
+59%
|
-1.87
-8%
|
-1.83
+2%
|
-1.72
+6%
|
-2.06
-20%
|
-1.69
+18%
|
-1.47
+13%
|
-1.3
+12%
|
-0.53
+59%
|
-2.11
-298%
|
|
Switch to:
Switch to:
See Also
Discover More
